Prime Medicine
Sarah Cappucci has worked as a Lab Manager, Operations at Prime Medicine, Inc. since September 2022. Prior to that, they were employed at FogPharma, where they held multiple roles including Senior Research Associate from March 2020 to August 2022, Research Associate II from March 2019 to March 2020, and Research Associate from August 2018 to March 2019. Before joining FogPharma, Sarah worked as a Peptide Technician at New England Peptide from May 2016 to August 2018.
Sarah Cappucci completed their undergraduate education at Franklin Pierce University, where they obtained a Bachelor's degree in Health Science in the field of Health Science. Sarah attended from 2012 to 2016. Afterward, Sarah pursued further education at the Massachusetts College of Pharmacy and Health Sciences. From 2016 to 2018, they obtained a Master's degree in Clinical Research.
This person is not in any offices
Prime Medicine
4 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.